Figure 2. Trial eligibility of adults recommended additional antihypertensive pharmacologic treatment by the American College of Cardiology/American Heart Association (ACC/AHA) guideline, by diabetes mellitus status and age.

A, Adults without diabetes mellitus; (B) adults with diabetes mellitus. Individuals recommended additional antihypertensive pharmacologic treatment include those not previously taking any antihypertensives and those currently taking antihypertensives but above the ACC/AHA guideline goal of 130/80 mm Hg. Striped section refers to individuals whose estimated cardiovascular risk was lower than required for trial inclusion and who met at least 1 exclusion criteria.